|
Striking the right balance: optimizing conditioning regimens for unrelated donor bone marrow transplant for severe aplastic anemia.
|
May 2012
|
Biol Blood Marrow Transplant
|
aplastic anemia
|
|
Stem cell transplants for myelodysplastic syndromes: refining the outcome predictions
|
Oct 2014
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
Stem Cell Transplant from Unrelated Donor in Patients with Severe Aplastic Anemia: Indications, Donor Selection, Conditioning, GVHD Prophylaxis
|
Feb 2015
|
Curr Drug Targets
|
aplastic anemia
|
|
Stem cell origin of myelodysplastic syndromes
|
Dec 2013
|
Oncogene
|
myelodysplastic syndromes (MDS)
|
|
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage specific expansion and harbor genetic and epigenetic alterations.
|
Jul 2012
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Stem and progenitor cell alterations in myelodysplastic syndromes
|
Feb 2017
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
STAT3-mutations indicate the presence of subclinical T cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients.
|
Aug 2013
|
Blood
|
aplastic anemia
|
|
Standardizing the Initial Evaluation for Myelodysplastic Syndromes.
|
Nov 2013
|
Curr Hematol
|
myelodysplastic syndromes (MDS)
|
|
Standardized High-Sensitivity Flow Cytometry Testing for Paroxysmal Nocturnal Hemoglobinuria in Children with Acquired Bone Marrow Failure Disorders: A Single Center U.S. Study
|
Jun 2017
|
Cytometry B Clin Cytom
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group
|
Feb 2012
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
